🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a phase I/II study to determine the safety and efficacy of AM...
Status
Completed
Location
Washington University
Start Date
2007-07
Trial ID
NCT00512252
Treatments Being Tested
Pancreatic, ovarian and colorectal cancers are difficult to treat using che...
Status
Completed
Location
Addenbrookes Hospital
Start Date
2015-06
Trial ID
NCT02179970
Treatments Being Tested
This is a 2-part study of mavorixafor in participants diagnosed with chroni...
Status
Completed
Location
USF Health Department of Pediatrics
Start Date
2021-10-16
Trial ID
NCT04154488
Treatments Being Tested
This study will determine how safely and well people can tolerate AMD3100 a...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2006-06-14
Trial ID
NCT00322127
Treatments Being Tested
This is multicentric, interventional, non farmacological and prospective st...
Status
Active Not Recruiting
Location
Istitute Nazionale Tumori - Fondazione G. Pascale
Start Date
2021-01-18
Trial ID
NCT05818865
Treatments Being Tested
This pilot phase IIb trial studies how well pembrolizumab and CXCR4 antagon...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2016-12-01
Trial ID
NCT02907099
Treatments Being Tested
Treatment Study to assess of safety and efficiency of conditioning with Ple...
Status
Unknown
Location
Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology
Start Date
2016-06
Trial ID
NCT03019809
Treatments Being Tested
This research study is studying Ulocuplumab combined with ibrutinib as a po...
Status
Terminated
Location
Dana Farber Cancer Institute
Start Date
2017-10-20
Trial ID
NCT03225716
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of BMS-9...
Status
Completed
Location
Uab Comprehensive Cancer Center
Start Date
2010-08
Trial ID
NCT01120457
Treatments Being Tested
Down regulation of CD9 in TEL/AML1-positive ALL is addressed in motility as...
Status
Completed
Location
Rennes University Hospital
Start Date
2010-11
Trial ID
NCT01282593
Treatments Being Tested